Go Pro
→ Your book is inside (From Profits Run) (Ad)tc pixel Free DYNT Stock Alerts

Dynatronics (DYNT) Competitors

Dynatronics logo
Compare

DYNT vs. FEED, TNON, BBLG, PTHL, and IVF

Should you buy Dynatronics stock or one of its competitors? MarketBeat compares Dynatronics with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Dynatronics include Nanovibronix (FEED), Tenon Medical (TNON), Bone Biologics (BBLG), Pheton (PTHL), and INVO Fertility (IVF). These companies are all part of the "medical equipment" industry.

How does Dynatronics compare to Nanovibronix?

Nanovibronix (NASDAQ:FEED) and Dynatronics (NASDAQ:DYNT) are both small-cap medical equipment companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, media sentiment, dividends, risk, valuation, profitability and institutional ownership.

Dynatronics has a net margin of -8.35% compared to Nanovibronix's net margin of -923.20%. Dynatronics' return on equity of -41.81% beat Nanovibronix's return on equity.

Company Net Margins Return on Equity Return on Assets
Nanovibronix-923.20% -54.25% -43.10%
Dynatronics -8.35%-41.81%-9.56%

In the previous week, Nanovibronix had 1 more articles in the media than Dynatronics. MarketBeat recorded 1 mentions for Nanovibronix and 0 mentions for Dynatronics. Nanovibronix's average media sentiment score of 0.00 equaled Dynatronics'average media sentiment score.

Company Overall Sentiment
Nanovibronix Neutral
Dynatronics Neutral

16.4% of Nanovibronix shares are held by institutional investors. Comparatively, 4.2% of Dynatronics shares are held by institutional investors. 1.4% of Nanovibronix shares are held by company insiders. Comparatively, 2.9% of Dynatronics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Dynatronics has higher revenue and earnings than Nanovibronix. Nanovibronix is trading at a lower price-to-earnings ratio than Dynatronics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nanovibronix$2.55M0.99-$18.18M-$8.82N/A
Dynatronics$33.60M0.00-$2.70M-$1.35N/A

Nanovibronix has a beta of 1.56, suggesting that its stock price is 56% more volatile than the broader market. Comparatively, Dynatronics has a beta of 0.31, suggesting that its stock price is 69% less volatile than the broader market.

Given Dynatronics' higher probable upside, analysts clearly believe Dynatronics is more favorable than Nanovibronix.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nanovibronix
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Dynatronics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

Dynatronics beats Nanovibronix on 9 of the 13 factors compared between the two stocks.

How does Dynatronics compare to Tenon Medical?

Dynatronics (NASDAQ:DYNT) and Tenon Medical (NASDAQ:TNON) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, profitability, analyst recommendations, risk, dividends, earnings and valuation.

Dynatronics has higher revenue and earnings than Tenon Medical. Tenon Medical is trading at a lower price-to-earnings ratio than Dynatronics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Dynatronics$33.60M0.00-$2.70M-$1.35N/A
Tenon Medical$3.94M0.61-$12.56M-$1.29N/A

Dynatronics has a beta of 0.31, meaning that its share price is 69% less volatile than the broader market. Comparatively, Tenon Medical has a beta of 1.36, meaning that its share price is 36% more volatile than the broader market.

4.2% of Dynatronics shares are owned by institutional investors. Comparatively, 22.7% of Tenon Medical shares are owned by institutional investors. 2.9% of Dynatronics shares are owned by insiders. Comparatively, 17.7% of Tenon Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Dynatronics has a net margin of -8.35% compared to Tenon Medical's net margin of -270.09%. Dynatronics' return on equity of -41.81% beat Tenon Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Dynatronics-8.35% -41.81% -9.56%
Tenon Medical -270.09%-907.60%-110.17%

Given Dynatronics' higher possible upside, research analysts plainly believe Dynatronics is more favorable than Tenon Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Dynatronics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Tenon Medical
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, Dynatronics' average media sentiment score of 0.00 equaled Tenon Medical'saverage media sentiment score.

Company Overall Sentiment
Dynatronics Neutral
Tenon Medical Neutral

Summary

Dynatronics beats Tenon Medical on 7 of the 13 factors compared between the two stocks.

How does Dynatronics compare to Bone Biologics?

Dynatronics (NASDAQ:DYNT) and Bone Biologics (NASDAQ:BBLG) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, profitability, earnings, valuation, institutional ownership, analyst recommendations, dividends and risk.

Given Dynatronics' higher probable upside, analysts clearly believe Dynatronics is more favorable than Bone Biologics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Dynatronics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Bone Biologics
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Dynatronics has a beta of 0.31, meaning that its share price is 69% less volatile than the broader market. Comparatively, Bone Biologics has a beta of 0.9, meaning that its share price is 10% less volatile than the broader market.

Bone Biologics has a net margin of 0.00% compared to Dynatronics' net margin of -8.35%. Dynatronics' return on equity of -41.81% beat Bone Biologics' return on equity.

Company Net Margins Return on Equity Return on Assets
Dynatronics-8.35% -41.81% -9.56%
Bone Biologics N/A -50.47%-47.40%

In the previous week, Dynatronics' average media sentiment score of 0.00 equaled Bone Biologics'average media sentiment score.

Company Overall Sentiment
Dynatronics Neutral
Bone Biologics Neutral

4.2% of Dynatronics shares are owned by institutional investors. Comparatively, 34.3% of Bone Biologics shares are owned by institutional investors. 2.9% of Dynatronics shares are owned by company insiders. Comparatively, 5.6% of Bone Biologics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Dynatronics has higher revenue and earnings than Bone Biologics. Bone Biologics is trading at a lower price-to-earnings ratio than Dynatronics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Dynatronics$33.60M0.00-$2.70M-$1.35N/A
Bone BiologicsN/AN/A-$3.11M-$2.27N/A

Summary

Dynatronics beats Bone Biologics on 7 of the 12 factors compared between the two stocks.

How does Dynatronics compare to Pheton?

Pheton (NASDAQ:PTHL) and Dynatronics (NASDAQ:DYNT) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, earnings, institutional ownership, dividends, valuation, media sentiment, analyst recommendations and risk.

Given Dynatronics' higher probable upside, analysts plainly believe Dynatronics is more favorable than Pheton.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Pheton
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Dynatronics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Pheton has a net margin of 0.00% compared to Dynatronics' net margin of -8.35%. Pheton's return on equity of 0.00% beat Dynatronics' return on equity.

Company Net Margins Return on Equity Return on Assets
PhetonN/A N/A N/A
Dynatronics -8.35%-41.81%-9.56%

In the previous week, Pheton's average media sentiment score of 0.00 equaled Dynatronics'average media sentiment score.

Company Overall Sentiment
Pheton Neutral
Dynatronics Neutral

4.2% of Dynatronics shares are held by institutional investors. 2.9% of Dynatronics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Pheton has higher earnings, but lower revenue than Dynatronics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Pheton$305.22K6.09-$660KN/AN/A
Dynatronics$33.60M0.00-$2.70M-$1.35N/A

Pheton has a beta of 5.4, meaning that its stock price is 440% more volatile than the broader market. Comparatively, Dynatronics has a beta of 0.31, meaning that its stock price is 69% less volatile than the broader market.

Summary

Pheton beats Dynatronics on 6 of the 10 factors compared between the two stocks.

How does Dynatronics compare to INVO Fertility?

Dynatronics (NASDAQ:DYNT) and INVO Fertility (NASDAQ:IVF) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, risk, valuation, dividends, earnings, profitability, media sentiment and institutional ownership.

INVO Fertility has a consensus target price of $20.00, indicating a potential upside of 1,823.08%. Given INVO Fertility's stronger consensus rating and higher possible upside, analysts clearly believe INVO Fertility is more favorable than Dynatronics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Dynatronics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
INVO Fertility
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
2.50

Dynatronics has a beta of 0.31, indicating that its share price is 69% less volatile than the broader market. Comparatively, INVO Fertility has a beta of 2.28, indicating that its share price is 128% more volatile than the broader market.

4.2% of Dynatronics shares are held by institutional investors. Comparatively, 12.0% of INVO Fertility shares are held by institutional investors. 2.9% of Dynatronics shares are held by company insiders. Comparatively, 0.4% of INVO Fertility shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Dynatronics has higher revenue and earnings than INVO Fertility. INVO Fertility is trading at a lower price-to-earnings ratio than Dynatronics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Dynatronics$33.60M0.00-$2.70M-$1.35N/A
INVO Fertility$6.84M0.27-$25.13M-$352.18N/A

Dynatronics has a net margin of -8.35% compared to INVO Fertility's net margin of -183.75%. Dynatronics' return on equity of -41.81% beat INVO Fertility's return on equity.

Company Net Margins Return on Equity Return on Assets
Dynatronics-8.35% -41.81% -9.56%
INVO Fertility -183.75%-420.62%-45.21%

In the previous week, Dynatronics' average media sentiment score of 0.00 equaled INVO Fertility'saverage media sentiment score.

Company Overall Sentiment
Dynatronics Neutral
INVO Fertility Neutral

Summary

Dynatronics beats INVO Fertility on 7 of the 13 factors compared between the two stocks.

Get Dynatronics News Delivered to You Automatically

Sign up to receive the latest news and ratings for DYNT and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DYNT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DYNT vs. The Competition

Export
MetricDynatronicsSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$653K$42.63M$6.86B$12.27B
Dividend YieldN/A1.08%2.67%9.36%
P/E Ratio-0.0118.1227.2423.92
Price / SalesN/A29.51581.32113.62
Price / CashN/A18.8629.0548.09
Price / BookN/A9.2010.746.18
Net Income-$2.70M-$16.99M$3.59B$331.89M

Dynatronics Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DYNT
Dynatronics
N/AN/AN/AN/A$653K$33.60MN/A200
FEED
Nanovibronix
0.8858 of 5 stars		$0.42
-8.6%		N/AN/A$2.56M$2.55MN/A20
TNON
Tenon Medical
0.2739 of 5 stars		$0.20
-3.2%		N/A-80.9%$2.35M$3.94MN/A8
BBLG
Bone Biologics
0.4472 of 5 stars		$1.24
-2.0%		N/A-59.1%$2.22MN/AN/A2
PTHL
Pheton
N/A$0.33
+0.7%		N/A-98.7%$2.15M$305.22KN/A11

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:DYNT) was last updated on 7/20/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
My next big call (under $1)
17,556% on KDA. Here's what I'm buying now. It's a coin under $1.00 that most investors have never heard of...
Crypto 101 Media | Sponsoredtc pixel
Buy this stock tomorrow
Marc Chaikin, founder of Chaikin Analytics, is flagging a little-known company that just secured a partnership...
Chaikin Analytics | Sponsoredtc pixel
Trump’s $250 Bill – See Immediately
Former Goldman Sachs VP Dr. David Eifrig is warning that July 28 could trigger the biggest wealth reset in mod...
Stansberry Research | Sponsoredtc pixel
This same-day trade is getting a lot of attention
Zero-days-to-expiration trades happen every single day - and most traders either ignore them or use them wrong...
Base Camp Trading | Sponsoredtc pixel
Man who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown”
In 2016, major election models gave Hillary Clinton a 99% chance of winning - but former CIA and Pentagon advi...
Paradigm Press | Sponsoredtc pixel
Print this and keep it by your screen
Ever been right about a stock's direction and still lost money on the trade? It's almost never bad luck - it's...
Profits Run | Sponsoredtc pixel
Where to Put $100 Before Trump's New Tech Law Rolls Out
The Financial Times says a new tech law puts America 'on the verge of a financial revolution.' Yahoo Finance e...
Brownstone Research | Sponsoredtc pixel